STOCK TITAN

Omnicell to Release Third Quarter 2021 Financial Results on November 2, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Omnicell, Inc. (NASDAQ: OMCL) will report its third-quarter 2021 financial results on November 2, 2021, before market open. A conference call is scheduled for 8:30 a.m. ET the same day to discuss these results. As a leader in medication management solutions, Omnicell aims to enhance pharmacy care delivery through automation and technology. The company has over 7,000 facilities utilizing its solutions to improve operational efficiency, patient safety, and adherence to prescriptions.

Positive
  • Upcoming earnings release expected to provide insights on financial health.
  • Strong market presence with over 7,000 facilities using Omnicell solutions.
Negative
  • None.

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter of 2021 before the open of the market on Tuesday, November 2, 2021. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.

All interested parties are invited to listen to the live call and presentation by dialing (855) 451-1210 in the U.S. or (236) 714-3867 in international locations. The Conference ID is 5688577. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/.

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings.

Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

To learn more, visit www.omnicell.com. From time to time, Omnicell may use the Company's investor relations site and other online social media channels, including its Twitter handle www.twitter.com/omnicell, LinkedIn page www.linkedin.com/company/omnicell, and Facebook page www.facebook.com/omnicellinc, to disclose material non-public information and comply with its disclosure obligations under Regulation Fair Disclosure ("FD").

Omnicell and the Omnicell logo are registered trademarks of Omnicell, Inc. in the United States and other countries.

OMCL-E

Kathleen Nemeth

VP, Investor Relations

ir@omnicell.com

Source: Omnicell, Inc.

FAQ

What date will Omnicell release its Q3 2021 financial results?

Omnicell will release its Q3 2021 financial results on November 2, 2021.

What time is the Omnicell conference call for Q3 2021 results?

The conference call for Omnicell's Q3 2021 results is scheduled for 8:30 a.m. ET on November 2, 2021.

How can I access the Omnicell Q3 2021 conference call?

The Omnicell Q3 2021 conference call can be accessed by dialing (855) 451-1210 in the U.S. or (236) 714-3867 internationally, using Conference ID 5688577.

Where can I find Omnicell's financial results after they are released?

Omnicell's financial results will be available in the Investor Relations section of their website.

Omnicell Inc

NASDAQ:OMCL

OMCL Rankings

OMCL Latest News

OMCL Stock Data

2.08B
45.50M
1.56%
100.97%
3.59%
Health Information Services
Electronic Computers
Link
United States of America
FORT WORTH